Brandon Couillard
Stock Analyst at Wells Fargo
(4.71)
# 156
Out of 5,131 analysts
174
Total ratings
67.96%
Success rate
19.54%
Average return
Main Sectors:
Stocks Rated by Brandon Couillard
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAT Waters | Maintains: Equal-Weight | $385 → $415 | $393.68 | +5.42% | 7 | Dec 15, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Overweight | $635 → $675 | $615.45 | +9.68% | 8 | Dec 15, 2025 | |
| RVTY Revvity | Maintains: Equal-Weight | $102 → $107 | $103.89 | +2.99% | 3 | Dec 15, 2025 | |
| RGEN Repligen | Maintains: Overweight | $175 → $190 | $168.40 | +12.83% | 3 | Dec 15, 2025 | |
| MTD Mettler-Toledo International | Maintains: Equal-Weight | $1,400 → $1,450 | $1,491.99 | -2.81% | 7 | Dec 15, 2025 | |
| MLAB Mesa Laboratories | Maintains: Equal-Weight | $75 → $83 | $83.96 | -1.14% | 4 | Dec 15, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Overweight | $4 → $4.5 | $3.94 | +14.21% | 2 | Dec 15, 2025 | |
| DHR Danaher | Maintains: Equal-Weight | $230 → $240 | $239.00 | +0.42% | 5 | Dec 15, 2025 | |
| BRKR Bruker | Maintains: Overweight | $48 → $55 | $53.41 | +2.98% | 7 | Dec 15, 2025 | |
| NTRA Natera | Maintains: Equal-Weight | $190 → $205 | $235.45 | -12.93% | 3 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $93 → $120 | $107.57 | +11.56% | 2 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $140 → $155 | $119.24 | +29.99% | 6 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $14 → $18 | $20.57 | -12.49% | 4 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $110 | $99.15 | +10.94% | 1 | Dec 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $150 → $175 | $147.99 | +18.25% | 25 | Nov 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $90 → $105 | $102.23 | +2.71% | 19 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $59 → $70 | $66.56 | +5.17% | 2 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6 → $6.5 | $6.57 | -1.07% | 3 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $265 → $340 | $323.00 | +5.26% | 13 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $265 → $340 | $324.85 | +4.66% | 13 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $19 → $16 | $12.28 | +30.29% | 5 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $260 | $172.00 | +51.16% | 11 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $77 → $80 | $76.13 | +5.08% | 6 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $30 → $23 | $23.38 | -1.63% | 1 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $13 | $1.99 | +553.27% | 1 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.69 | - | 11 | Nov 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $1.68 | +554.76% | 2 | Oct 13, 2017 |
Waters
Dec 15, 2025
Maintains: Equal-Weight
Price Target: $385 → $415
Current: $393.68
Upside: +5.42%
Thermo Fisher Scientific
Dec 15, 2025
Maintains: Overweight
Price Target: $635 → $675
Current: $615.45
Upside: +9.68%
Revvity
Dec 15, 2025
Maintains: Equal-Weight
Price Target: $102 → $107
Current: $103.89
Upside: +2.99%
Repligen
Dec 15, 2025
Maintains: Overweight
Price Target: $175 → $190
Current: $168.40
Upside: +12.83%
Mettler-Toledo International
Dec 15, 2025
Maintains: Equal-Weight
Price Target: $1,400 → $1,450
Current: $1,491.99
Upside: -2.81%
Mesa Laboratories
Dec 15, 2025
Maintains: Equal-Weight
Price Target: $75 → $83
Current: $83.96
Upside: -1.14%
Maravai LifeSciences Holdings
Dec 15, 2025
Maintains: Overweight
Price Target: $4 → $4.5
Current: $3.94
Upside: +14.21%
Danaher
Dec 15, 2025
Maintains: Equal-Weight
Price Target: $230 → $240
Current: $239.00
Upside: +0.42%
Bruker
Dec 15, 2025
Maintains: Overweight
Price Target: $48 → $55
Current: $53.41
Upside: +2.98%
Natera
Dec 15, 2025
Maintains: Equal-Weight
Price Target: $190 → $205
Current: $235.45
Upside: -12.93%
Dec 15, 2025
Maintains: Overweight
Price Target: $93 → $120
Current: $107.57
Upside: +11.56%
Dec 15, 2025
Maintains: Equal-Weight
Price Target: $140 → $155
Current: $119.24
Upside: +29.99%
Dec 15, 2025
Maintains: Equal-Weight
Price Target: $14 → $18
Current: $20.57
Upside: -12.49%
Dec 1, 2025
Initiates: Equal-Weight
Price Target: $110
Current: $99.15
Upside: +10.94%
Nov 25, 2025
Maintains: Overweight
Price Target: $150 → $175
Current: $147.99
Upside: +18.25%
Nov 24, 2025
Downgrades: Hold
Price Target: $90 → $105
Current: $102.23
Upside: +2.71%
Nov 6, 2025
Maintains: Overweight
Price Target: $59 → $70
Current: $66.56
Upside: +5.17%
Nov 5, 2025
Maintains: Equal-Weight
Price Target: $6 → $6.5
Current: $6.57
Upside: -1.07%
Oct 30, 2025
Maintains: Equal-Weight
Price Target: $265 → $340
Current: $323.00
Upside: +5.26%
Oct 30, 2025
Maintains: Equal-Weight
Price Target: $265 → $340
Current: $324.85
Upside: +4.66%
Aug 4, 2025
Maintains: Overweight
Price Target: $19 → $16
Current: $12.28
Upside: +30.29%
Jan 23, 2025
Maintains: Buy
Price Target: $285 → $260
Current: $172.00
Upside: +51.16%
Jan 23, 2025
Maintains: Hold
Price Target: $77 → $80
Current: $76.13
Upside: +5.08%
Feb 9, 2024
Downgrades: Hold
Price Target: $30 → $23
Current: $23.38
Upside: -1.63%
Jul 13, 2021
Initiates: Buy
Price Target: $13
Current: $1.99
Upside: +553.27%
Nov 2, 2017
Downgrades: Hold
Price Target: n/a
Current: $2.69
Upside: -
Oct 13, 2017
Maintains: Buy
Price Target: $9 → $11
Current: $1.68
Upside: +554.76%